Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132973 |
| TARO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2019-08-06 | 2019-08-19 | 90767 |
| TARO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-01-04 | 2020-08-28 | 102269 |
| TARO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-01-31 | 2021-06-16 | 132976 |
| PRO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-09-07 | 2017-11-09 | 21239 |
| PRO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-08-24 | 2017-09-22 | 20226 |
| PRO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-05-09 | 2017-07-31 | 9735 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-04-07 | 2018-02-15 | 5951 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-10-23 | 2018-02-15 | 26702 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-04-04 | 2017-09-08 | 5319 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |